KIM D BLICKENSTAFF
CIK 1238913 · Executive Chairman · last filed 2026-05-26
KIM D BLICKENSTAFF is an Executive Chairman who has filed 84 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for NUVB, was dated May 26, 2026. Across all open-market trades the lifetime net is −$159.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.15M
7
84
-$158.96M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NUVB | Director | — | $6.68 | — | $0 | 1 | 2026-05-26 |
| Nuvation Bio Inc. (NUVB.WS) Delisted | Director | 172,189 | $0.01 | $878 | $500.1K | 8 | 2025-05-23 |
| TNDM | Director | 213,038 | $18.39 | $3.92M | -$146.63M | 46 | 2024-11-22 |
| MEDIVATION, INC. (MDVN) Delisted | Director | 43,242 | — | — | -$12.84M | 18 | 2016-09-26 |
| SENORX INC (SENO) Delisted | Director | 0 | — | — | $0 | 5 | 2010-07-07 |
| BIOSITE INC (BSTE) Delisted | Chairman & CEO | 0 | — | — | $0 | 2 | 2007-07-02 |
| DXCM | Director | 16,416 | $75.25 | $1.24M | $0 | 1 | 2007-05-25 |
Recent Filings
84 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | NUVB | Grant (A) | — | $0 | EDGAR |
| 2025-05-23 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-11-22 | TNDM | Sell (S) | −40,000 | -$1.24M | EDGAR |
| 2024-11-21 | TNDM | Notice (144) | −30,000 | -$900.0K | EDGAR |
| 2024-11-20 | TNDM | Notice (144) | −10,000 | -$1.20M | EDGAR |
| 2024-09-05 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | Nuvation Bio Inc. (NUVB.WS) Delisted | Buy (P) | +172,189 | $500.1K | EDGAR |
| 2024-05-24 | TNDM | Mixed | +4,434 | $229.4K | EDGAR |
| 2023-05-26 | TNDM | Mixed | +2,757 | $0 | EDGAR |
| 2023-05-17 | Nuvation Bio Inc. (NUVB.WS) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.